Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...

Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health ...

Scientists from Columbia University and McGill University have discovered that high levels of a brain chemical called SGK1 ...

Alto Neuroscience, Inc. ( ($ANRO) ) just unveiled an announcement. On October 19, 2025, Alto Neuroscience, Inc. announced a private placement ...

A recent study found that a single dose of LSD effectively treated symptoms of anxiety for an astonishing 12 weeks.

When used for mental health treatment, a dose of ketamine — typically half a milligram per kilogram of body weight, less than for anesthesia — creates a mildly altered state of consciousness, Goldman ...

Sexual problems are common for people with depression. SSRIs (like Prozac or escitalopram) are often prescribed to improve ...

The FDA has granted Breakthrough Therapy designation to BPL-003 (mebufotenin benzoate) nasal spray for adults with treatment-resistant depression.

It stands for Psychiatric Renewal Through Innovative Solutions and Methods. There are a couple of high profile treatments, ...

Mission Prep, a specialized adolescent mental health clinic with centers across California and Virginia, has released a ...

Atai Life Sciences received breakthrough therapy designation from the FDA for its nasal spray for treatment-resistant depression. The biopharmaceutical company said Thursday the designation may ...

Scientists in Spain have identified a surprising link between the amino acid proline,found in foods like beef and fish, and ...